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Emergence of a Streptococcus 
dysgalactiae subspecies equisimilis 
stG62647-lineage associated with 
severe clinical manifestations
Oddvar Oppegaard1,2, Haima Mylvaganam3, Steinar Skrede1,2, Paul Christoffer Lindemann3 & 
Bård Reiakvam Kittang4
Increasing incidence rates of invasive Streptococcus dysgalactiae subspecies equisimilis (SDSE) 
infections have been reported worldwide, but the evolutionary mechanisms underlying this 
development remain elusive. Through prospective surveillance of invasive SDSE infections in western 
Norway, we observed the emergence of a novel and virulent SDSE genotype, stG62647. This emm-
type, rarely encountered as a cause of invasive disease during 1999–2012, emerged in 2013 as the 
predominant SDSE-genotype. The stG62647-infections were associated with an aggressive clinical 
course, including the occurrence of streptococcal toxic shock syndrome, necrotizing soft-tissue 
infections and endocarditis. All the invasive stG62647-isolates were subjected to whole genome 
sequencing, attempting to explore the genetic events underpinning its epidemicity. Although 10% of 
the genomes was unique for stG62647-genotype, notably 18 out of 19 isolates contained a disrupted 
streptococcal invasive locus (sil) due to the insertion of a transposase, IS1548, into the silB-gene. We 
postulate that the virulence of stG6267-isolates could be partly attributable to the abrogation of the 
attenuating control normally exerted by this regulon, although experimental verification was not 
performed. To the best of our knowledge, this is the first study employing large scale whole genome 
sequencing to illuminate the genetic landscape of epidemic lineages in SDSE.
Streptococcus dysgalactiae subspecies equisimilis (SDSE) is an emerging human pathogen with a disease spectrum 
similar to the closely related Streptococcus pyogenes (S. pyogenes)1, 2. Although SDSE has been regarded as less 
virulent than S. pyogenes, severe clinical manifestations have been documented, including necrotizing soft tissue 
infection and streptococcal toxic shock syndrome3, 4. SDSE and S. pyogenes also share extensive genetic homology, 
including genes encoding conserved virulence factors (emm, streptolysin O, streptolysin S, streptokinase and c5a 
peptidase) and virulence regulators (control of virulence-regulon [covRS] and streptococcal invasive locus [sil])5, 6.
During the past decade, an upsurge in the incidence of invasive SDSE disease has been documented world-
wide, in some geographic regions even surpassing the incidence of invasive S. pyogenes infections7–9. In our region 
of western Norway, SDSE is currently the leading cause of invasive beta-haemolytic disease2. The epidemiological 
and molecular events promoting this development, however, have yet to be elucidated. Several studies involving 
whole genome sequencing have investigated the genomic events leading to epidemic spread of hypervirulent S. 
pyogenes clones, revealing mutations in virulence regulators and virulence genes, as well as the acquisition of 
novel bacteriophages10, 11. Similar studies have not been conducted for SDSE.
Mutations in regulons normally exerting negative transcriptional control of virulence genes have been demon-
strated to induce the transition from a mild to a more invasive phenotype, particularly in the covRS-regulon and 
the sil-locus12, 13. covRS is a two-component regulatory system, comprising the genes covR and covS, controlling 
the expression of approximately 10% of the S. pyogenes transcriptome14. covRS-mutants have an upregulated 
expression of many virulence factors, increased resistance to phagocytosis, and increased virulence potential 
in murine bacteraemia models14. sil is a virulence-regulon found in approximately 80% of SDSE and 25% of S. 
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pyogenes, and S. pyogenes-isolates with mutations in this locus have been reported to cause infections pursuing 
an aggressive clinical course6, 13. sil comprises genes encoding a putative two component regulator (silA and silB), 
a transporter system (silD and silE), and two small pheromone-like peptides (silC and silCR) with differing func-
tions; silC being linked to virulence, whereas silCR is associated with competence, bacterial quorum sensing, and 
attenuation of virulence in both SDSE and S. pyogenes-infections15.
Through prospective registration and genotyping of invasive SDSE-disease from 2012, we identified an out-
break of the SDSE emm-type stG62647 in our health region. Here, we present a detailed epidemiological and 
molecular characterization of the outbreak, and through whole genome sequencing we attempted to unravel the 
genetic rationale for this virulent genotype, with particular emphasis on acquired bacteriophages, the repertoire 
of virulence factors, and mutations in the virulence regulons covRS and sil.
Materials and Methods
Study setting and definitions. Health Region Bergen in Western Norway has a catchment area of 430 000 
inhabitants, and comprises the tertiary care hospital Haukeland University Hospital, along with the two second-
ary care hospitals Haraldsplass Deaconess Hospital and Voss Hospital. Data on the epidemiology of SDSE-disease 
in this region in the period 1999–2013 has previously been reported2. From 2012 to 2015 SDSE isolates obtained 
from invasive disease were prospectively collected, and clinical information was abstracted from patient records. 
All stG62647-isolates during 1999–2015 were included in the study. Invasive disease was defined as isolation of 
SDSE from a sterile site, or from a non-sterile site in association with verified necrotizing soft tissue infections. 
Clinical entities and streptococcal toxic shock syndrome were defined as previously described2. Severe disease 
was defined as the presence of necrotizing soft tissue infection, endocarditis, streptococcal toxic shock syndrome 
or death ensuing within 30 days of admission.
Bacterial isolates, DNA extraction and sequencing. All isolates displayed large colony size (>0.5 mm 
in diameter after 24 hours) and β-haemolysis on 5% sheep blood agar. Serogroup specificity had previously been 
determined using a rapid agglutination test (Oxoid Streptococcal Grouping Kit, Hampshire, UK), and species 
identity had been confirmed by matrix-assisted laser desorption ionization-time of flight mass spectrometry 
(MALDI-ToF MS), using Microflex™ with the MALDI Biotyper database (Bruker Daltonik, Bremen, Germany). 
Bacterial suspensions were pre-treated with Mutanolysin (M9901, Sigma-Aldrich, Dorset, UK), Lysozyme 
(L6876, Sigma-Aldrich) and Proteinase K (19133, Qiagen, Hilden, Germany), and genomic DNA was extracted 
using MagNA Pure 96 (Roche Life science). Genomic libraries were made using Nextera XT Kit (Illumina, Essex, 
UK), and 150 basepairs paired-end sequencing was performed on HiSeq. 4000 (Illumina).
Assembly, annotation and molecular characterization. Reads quality was assessed using FastQC 
(bioinformatics.bbsrc.ac.uk), and filtered using Trimmomatic16. Trimmed reads were submitted to Center for 
Genomic Epidemiology for online assembly by Spades17, and subsequent assessment with Quast18. Annotation 
was performed using RAST19. emm-type was determined by BLAST-search against the emm-type database 
curated by Centers for Disease Control (http://www.cdc.gov). Multilocus sequence typing (MLST) profiles were 
identified using the Center for Genomic Epidemiology website20, and novel MLST alleles and profiles were sub-
mitted to pubMLST (www.pubMLST.org). To compare the strains for variations across the whole genome, a 
single nucleotide polymorphism (SNP) based phylogenetic analysis was performed as previously described21. 
Of the six full genomes deposited in GenBank, S. dysgalactiae subspecies equisimilis ATCC 12394 (GenBank 
accession number CP002215) had the closest genetic resemblance to our stG62647-genomes, and was selected 
as a reference-genome in the SNP-analysis. Geneious version 10.0 was used to screen for the presence and 
mutation of selected virulence genes and regulators (Table 1)22. The selection of genes was adapted from the 
S. pyogenes-virulence factors listed in the Virulence Factors Database (www.mgc.ac.cn/VFs), with some minor 
modifications. Genomes were screened for bacteriophages by Phaster, and for Clustered Regularly Interspaced 
Short Palindromic Repeats (CRISPRs) using CRIPSRFinder23, 24.
Statistical analysis. Data were processed using SPSS PASW STATISTICS, version 21.0 (IBM SPSS Statistics 
for Windows, Version 21.0. Armonk, NY: IBM Corp). Categorical data were analysed using Fisher’s exact test, 
and non-parametric data were analysed with Mann Whitney U-test. A two-sided p-value ≤ 0.05 was considered 
statistically significant.
Ethical standards. The study underwent institutional ethics review and approval (2010/1406 Regional 
Ethics Committee West, Norway). Informed consent was obtained from participants. All experiments were car-
ried out in full accordance with the approved ethics applications specified above.
Results
Among 267 cases of invasive SDSE disease identified from 1999 to 2015, 19 cases were attributable to group C 
streptococci belonging to emm-type stG62647. The first patient was a German tourist presenting with bacterae-
mia, acute spondylodiscitis and streptococcal toxic shock syndrome in 2006. Two additional sporadic cases were 
identified in 2006 and 2010; the latter was referred from another health region. However, the last 16 cases were 
encountered within a relatively short time frame from March 2013 to August 2015. Consequently, stG62647 was 
the predominant emm-type during this period, accounting for >20% of all invasive SDSE-isolates. The temporal 
distribution of emm-types associated with invasive SDSE disease during 1999–2015 is depicted in Fig. 1.
The clinical characteristics of the 19 invasive infections associated with stG62647 are presented in Table 2. 
Median age was 70 years, and a male predominance was noted. Osteoarticular infection was the most frequent 
clinical entity (42%), followed by skin and soft-tissue infection (32%). Of note, approximately half of the patients 
experienced severe disease manifestations: two had necrotizing soft-tissue infections, one had endocarditis, five 
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developed streptococcal toxic shock syndrome, and three patients died within a few days after admission. Severe 
disease was significantly more frequent in cases associated with stG62647 than among patients infected with 
SDSE-isolates belonging to other emm-types during the study period (47/248, 19%, P = 0.01).
Gene Reference CC20 ST17 Phage Rep. SDSE
Adhesion
dltABCD-operon BAH81801–4 + + — +
ProteinF1/gfba U31115 — + — +
ProteinF2/fbaB/PFBP AB084272/AY612221 — — — −
fbaA AB040536 — — — +
Sof X83303 — — — −
sfbX AF335322 — — — −
gapC AF375662 + + — +
fbp54 BAH81758 + + — +
Shr BAH82346 + + — +
Lmb BAH81434 + + — +
sclA AY459361
Enzymes
Streptolysin O AB050249 + + — +
Streptolysin S AY033399 + + — +
Streptokinase BAH80750 + + — +
Streptodornase (sda) AAL98274 — — + —
Streptodornase B (sdaB) AAM80352 — — − —
Streptodornase D (sdaD) WP_048327803 — — + +
Streptodornase (sdn) BAH81602 — — + +
Mitogenic factor 2 AAL97446 — — + —
Mitogenic factor 3 KKC20252 — — + +
Mitogenic factor 4 AAM79702 — — + —
Phospholipase A2 AAM79811 — — + +
Immune evasion
drsG BAH81431 — + — +
Protein G M13825 + + — +
C5a-peptidase BAH81432 + + — +
hasA WP_011055113 — — — —
hasB WP_002992300 — — — —
hasC BAH82462 + + — +
Superantigens
speA U40453 — — + +
speB (protease) L26125 — — — —
speC M35514 — — + +
speG AB105080 + — — +
speH AF124500 — — + +
speI AF438524 — — + +
speJ AF321000 — — — —
speK WP_011054728 — — + —
speL WP_011017837 — — + —
speM AIT77602 — — + +
Ssa U48792 — — + −
smeZ AB046865 — — — +
Virulence regulon
covRS BAH80897/8 + + — +
Sil GQ184566 Mut — — +
Table 1. Genetic repertoire of the invasive stG62647-isolates. CC20, stG62647-isolates belonging to clonal 
complex 20; ST17, stG62647-isolate belonging to MLST-profile 17; Phage, bacteriophage-associated; Rep. SDSE, 
previously reported in SDSE; Mut, mutated. Symbols + and–denote presence or absence of genetic feature, 
respectively.
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Whole genome sequencing, MLST and SNP-analysis. The assembled genomes had an average 
genome-size of 2.1 Mbp, the mean coverage was ~50 fold, and the G + C-content was approximately 39%. MLST 
revealed a relatively uniform bacterial population, with 15 of the 19 invasive stG62647 isolates classified as ST20. 
Additionally, three isolates shared six out of seven alleles with ST20, and constituted the novel ST-profiles ST319, 
ST320 and ST321. These 18 isolates were designated Clonal Complex 20 (CC20). The T666-isolate, however, 
belonged to the unrelated MLST-profile ST17, an apparently promiscuous ST-profile shared by several other 
SDSE emm-types (pubMLST.org). The stG62647-genomes mapped to ~90% of the SDSE ATCC 12394 refer-
ence genome, and from a core genome of 1.86 Mbp, a total of 14 163 SNPs valid in all genomes were identified. 
The CC20-isolates differed by an average of 214 SNPs, ranging from 16 to 718. In comparison, the T666 isolate 
diverged from the CC20 isolates by ~8270 SNPs. The phylogenetic tree of the 19 outbreak isolates based on core 
genome SNP-analysis is depicted in Fig. 2.
Figure 1. The temporal distribution of emm-types associated with 267 cases of invasive SDSE-disease 
encountered during 1999–2015. stG62647 was the predominant emm-type in the period 2013–2015, comprising 
approximately 20% of the invasive SDSE-isolates. The category “Other” includes stG166b (12), stG2078 (9), 
stG652 (8), stC5345 (4), stC36 (2), stC2574 (2), stC3852 (2), stG4831 (2), stG5420 (2), stC1400 (1), stC7901 (1), 
stG12 (1), stG120 (1), stG245 (1), stG4222 (1), stG507 (1), stG653 (1), stG6792 (1), stG840 (1) and 29 isolates not 
available for emm-typing.
Case id. Year Sex Age SSTI NSTI OAI Other STSS Mors30
T267 2006 M 70 — — + — + —
T274 2006 F 93 — — — + — —
T437 2010 F 67 — — + — — —
T560 2013 F 87 — — + — — —
T562 2013 M 66 — — + — — —
T576 2013 M 28 — + — — + —
T599 2013 M 60 — — + — — —
T604 2014 M 61 — + — — + —
T606 2014 M 29 — — + — — —
T607 2014 M 86 + — — — — +
T619 2014 F 63 — — + — + —
T630 2014 M 77 + — — — + —
T642 2015 M 70 — — — + — —
T645 2015 M 88 + — — — — +
T653 2015 F 85 + — — — — —
T654 2015 M 63 — — + — — —
T655 2015 F 86 — — — + — +
T661 2015 M 77 + — — — — —
T666 2015 F 72 + — — — — —
Table 2. Clinical characteristics of the invasive stG6247-cases. Case id., case identity; SSTI, skin and soft-tissue 
infection; NSTI, necrotizing soft-tissue infection; OAI, osteoarticular infection; STSS, streptococcal toxic shock 
syndrome; Mors30, mortality within 30 days of admission; M, male; F, female. Other comprises nosocomial 
pneumonia (T274), prosthetic valve endocarditis (T642) and primary bacteremia (T655). Symbols + and–
denote presence or absence of clinical features, respectively.
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Bacteriophages and CRISPRs. Bacteriophages were detected in five isolates and none of them harboured 
more than one phage. Four out of five had similarities to bacteriophages previously documented in Streptococcus 
pyogenes: Two isolates possessed a 35.2 kb phage displaying 67% homology to Φ315.3, one isolate contained 
a 41.8 kb phage bearing 70% resemblance to Φ315.2, and one isolate accommodated a 49.6 kb phage showing 
60% identity to Φ315.5, all Φ315-phage-variants originally described in the Streptococcus pyogenes emm3 iso-
late, MGAS31525. Of note, these phages have been associated with the virulence genes mitogenic factor 4 (mf4), 
streptococcal superantigen (ssa) and streptococcus pyogenes exotoxin A (speA), respectively, but no phage-mediated 
virulence genes were detected in any of our isolates. The final bacteriophage consisted of a 49.6 kb element with-
out significant similarity to previously published phages of S. pyogenes. CRISPR-systems were detected in all 19 
stG62647-genomes, the majority harbouring two discrete loci. The number of CRISPR-spacers did not differ sig-
nificantly between isolates containing bacteriophages (median of 14 spacers, range 11 to 23) and isolates without 
phages (median of 16 spacers, range 11–22), P = 1.0. The distribution of bacteriophages and CRISPRs is presented 
in Table 3.
Virulence gene profiling. Whole genome screening of the 19 stG62647-isolates confirmed the presence 
of several established and putative virulence factors, shown in Table 1. The antiphagocytic hyaluronic acid 
capsule-operon has not previously been reported in SDSE, and accordingly only hasC was detected among our 
isolates. All 18 stG62647-isolates belonging to CC20 possessed speG, but lacked other differentially distributed 
virulence genes, such as gfba and drsG. Conversely, the ST17-isolate harboured both gfba and drsG, but lacked 
speG. No other streptococcal superantigens were identified.
A broad range of genes involved in adhesion were identified, including dltABCD-operon producing d-alanyl 
lipoteichoic acids mediating the initial contact between pathogen and host. Furthermore, two pilus-islands were 
discovered. These islands are also known as Fibronectin/Collagen/T-antigen-region (FCT) in S. pyogenes, and 
have been categorized into nine different FCT-regions according to their content and genomic arrangement26. 
The first pilus-island in the stG62647-isolates displayed a genetic structure similar to FCT-6-region, and the over-
all genetic identity to the FCT-6-region in the M2 S. pyogenes-isolate MGAS10270 (GenBank accession number 
CP000260) was 95%. The second pilus island did not concord with any of the nine reported FCT-regions of S. 
Figure 2. Phylogenetic tree of the stG62647-isolates based on core-genome SNP-analysis. (a) Phylogenetic tree 
of all 19 stG62647-isolates. (b) Phylogenetic tree of the 18 stg62647-isolates belonging to clonal complex 20. The 
ST17-isolate (T666) was omitted from the analysis to increase the phylogenetic resolution of the tree. Scales 
indicate substitutions per site. MLST-profile is indicated in parentheses.
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pyogenes. It had a structure resembling FCT-2, but had lost the terminal two transposases and the sortaseB-gene. 
However, it was structurally identical, and 95% homologous to an FCT-region found in the M58 S. pyogenes-strain 
GA40884 in GenBank (Accession number AWUA01000008).
Virulence regulatory systems. covRS was conserved among all the stG62647-isolates, and all alleles were 
100% identical. Compared to the covRS regulon in GGS124 (GenBank accession number AP010935), a single 
non-synonymous substitution in covS was noted, resulting in I421V.
The streptococcal invasive locus (sil) was absent in the ST17-isolate, but was detected in the remaining 
stG62647-isolates. However, in all the CC20-isolates, the silB-gene was truncated due to the insertion of a trans-
posable element after nucleotide 243 (Fig. 3). The transposase was 99% homologous to IS1548, a transposable ele-
ment of the ISaS1-family, previously reported in several beta-haemolytic streptococci27. To investigate if this was a 
common feature in SDSE, the sil-locus in the 23 SDSE-genomes currently in Genbank were examined (ncbi.nlm.
nih.gov/genome). None of them contained a transposase within the silB-gene, nor was this identified in any of the 
333S. pyogenes-genomes deposited in GenBank. Lastly, from our sample of 267 invasive SDSE isolates identified 
between 1999 and 2015, an additional 76 isolates, chosen to represent the diversity of clinical and molecular char-
acteristics, have been subjected to whole genome sequencing (Unpublished data). A transposable element within 
the silB-gene was not detected in any of these genomes, indicating that this is not a common genetic feature of 
SDSE-isolates within our geographical confines.
Isolate identity ST-type Bacteriophages Number of CRISPR-regions Total number of CRISPR- repeats
T267 ST20 — 2 15
T274 ST20 — 2 20
T437 ST20 — 2 20
T560 ST20 — 2 17
T562 ST20 — 3 19
T576 ST20 — 2 14
T599 ST20 — 3 21
T604 ST20 Φ315.3-like 2 11
T606 ST20 — 2 13
T607 ST20 Φ315.3-like 2 14
T619 ST321 — 2 22
T630 ST319 — 2 15
T642 ST20 — 3 20
T645 ST20 — 2 11
T653 ST20 — 2 11
T654 ST20 — 2 14
T655 ST320 Φ315.5-like 3 23
T661 ST20 Φ315.2-like 2 12
T666 ST17 ΦT666 - New 2 22
Table 3. Distribution of bacteriophages and CRISPRs. CRISPR, Clustered Regularly Interspaced Short 
Palindromic Repeats. The symbol – denotes the absence of bacteriophages.
Figure 3. Genetic arrangement of the streptococcal invasive locus in the CC20-isolates. The sil-locus in the 
CC20 isolates has a transposase, IS1548, inserted into the silB-gene. silB encodes a sensory kinase activating 
the putative DNA response regulator encoded by silA. This leads to increased transcription of the virulence 
attenuating pheromone encoded by silCR, and suppression of the virulence associated silC-gene. The SilC-
peptide is exported from the cell by the transporter-proteins SilD and SilE. Scale indicates nucleotide position. 
This disrupted sil-locus is deposited in GenBank under the accession code KY807567.
www.nature.com/scientificreports/
7SCieNtifiC REpORTs | 7: 7589  | DOI:10.1038/s41598-017-08162-z
Discussion
Streptococcus dysgalactiae subspecies equisimilis (SDSE) is increasingly implicated in invasive infections world-
wide, but the evolutionary events underlying this upsurge are unknown. With the present work, we have doc-
umented the recent emergence of a virulent SDSE genotype, stG62647, in western Norway, and delineated its 
clinical and genetic characteristics. To the best of our knowledge, this is the first study employing large scale 
whole genome sequencing to explore the genetic landscape of epidemic lineages in SDSE. Wang et al. charac-
terized an outbreak of tonsillopharyngitis caused by SDSE in Hong Kong, but they sequenced only one isolate28.
stG62647-isolates did not cause invasive SDSE-infections in our region until a few sporadic cases were 
encountered from 2006. However, in the period from March 2013 to August 2015 it became the predominant 
emm-type in our health-region, responsible for more than 20% of all invasive SDSE-disease, and comprising 80% 
of the invasive group C streptococcal-isolates. Although this emm-type has previously been reported from several 
countries and continents, its relative proportion has generally been below 5%, indicating mainly sporadic encoun-
ters8, 29, 30. Interestingly, in a recent study from our neighbouring country, Sweden, stG62647 was one of the most 
frequently occurring emm-types during 2008–2011, comprising 25% of the invasive SDSE-isolates identified31. 
Differently, Rantala et al. found only one stG62647-isolate among 140 invasive SDSE cases encountered in Finland 
between 1995 and 200432. Taken together, this might indicate that the emergence of a virulent stG62647-type in 
the Nordic countries is a fairly recent event.
Based on MLST data, the stG62647-isolates constituted a relatively homogenous group, with 15 out of 19 
belonging to ST20, and 18 out of 19 grouped together as CC20. However, SNP-analysis revealed a more diverse 
population, emphasizing the superior epidemiological resolution of a SNP-analysis compared to traditional 
methods. Moreover, it suggests that the genetic events resulting in the epidemiological spread of this genotype 
have occurred some time ago. The expected rates of spontaneous mutations and recombination events in SDSE 
have not been well defined, though, making conclusions on evolutionary relationships and clonality difficult.
Notably, half the patients in our study infected with stG62647-isolates experienced a fulminant clinical course, 
including streptococcal toxic shock syndrome and necrotizing soft-tissue infections. Such disease manifesta-
tions are usually associated with S. pyogenes, although our findings are in accordance with previous reports on 
stG62647. In Sweden, this emm-type was significantly associated with an invasive phenotype, and in a recent 
report from Austria stG62647 was linked to severe clinical manifestations31, 33. However, most epidemiological 
reports on SDSE genotypes comprise too few stG62647-isolates to evaluate its correlation with disease severity.
The streptococcal invasive locus (sil) has been demonstrated to repress bacterial virulence through the pro-
duction of the pheromone like peptide silCR13. This locus was initially described in an M14 S. pyogenes iso-
late procured from a patient with necrotizing soft-tissue infections, and the strain was discovered to have a 
missense-mutation in the silCR start-codon13. Subsequent experimental murine skin-infection models revealed 
these silCR-mutants to confer increased mortality and extensive skin necrosis, whereas concomitant adminis-
tration of synthetic silCR resulted in attenuated virulence13, 34. Surprisingly, all our CC20-isolates harboured a 
truncated silB-allele due to the insertion of an IS1548-transposon. This feature appears to be rare, and was neither 
identified among any of the SDSE- or S. pyogenes-genomes currently available in GenBank, nor in the genomes 
of contemporary invasive SDSE isolates from our health region. The silB-gene encodes a sensory kinase that 
activates the transcriptional regulator silA, leading to an upregulation of silCR-production and exportation, and 
concurrent suppression of silC15, 35. In a recent murine model study, SDSE grown in the presence of silCR caused 
a milder disease than the control group. Inversely, mice vaccinated against silCR developed a significantly more 
severe illness than non-vaccinated mice6. Although not experimentally verified, it is plausible that the lack of silB 
in our stG62647-isolates would impair the silCR-levels, and favour the production of the virulence associated 
silC-peptide. This would likely constitute a significant contribution to the aggressive phenotype associated with 
our stG62647-isolates belonging to CC20. Experimentally induced mutations in silB in M14 S. pyogenes-strains 
resulted in reduced virulence13, 36. However, those isolates concurrently contained a truncated silCR-gene, and the 
results are thus not readily transferable.
IS1548 is a transposable element of the ISAS1-family, initially described in invasive Streptococcus agalactiae 
strains, but subsequently also detected in S. pyogenes and SDSE27, 37. It encodes two putative proteins of 377 and 
62 amino acids, respectively, and has 19 bp imperfect inverted repeats at its termini. Interestingly, IS1548 has 
been reported to modulate the expression of several virulence factors in Streptococcus agalactiae. Al Safadi et al. 
demonstrated that the insertion of IS1548 immediately upstream of the laminin binding gene lmb, was associated 
with an ~5-fold increase both in the transcription of lmb, and in the phenotypic bacterial adhesion to laminin38. 
Conversely, insertion of IS1548 into the hylB and cpsD genes, abrogated the production of hyaluronidase and 
bacterial capsule, respectively37, 39. Of note, IS1548 has also been documented in the covRS-system in S. pyogenes. 
Several S. pyogenes-strains were passed through an experimental murine model, and spontaneous insertion of 
IS1548 into the covS-gene was observed in two isolates. These genetic alterations in the covRS-system rendered 
the bacteria more virulent and led to more extensive necrotic skin lesions12. Although mutational transition 
to a more virulent phenotype undoubtedly renders the bacteria more capable of invasive disease, it does not 
necessarily represent an evolutionary advantage. Trevino et al. showed that highly virulent covRS-mutated S. 
pyogenes-isolates indeed were significantly outcompeted by wild-type strains during growth in human saliva, 
indicating that different phenotypic properties might be required for a commensal state in the upper respiratory 
tract14. IS1548 has been suggested to mediate adaptive mutations, allowing the bacteria to switch between path-
ogenicity and commensalism27. Insertion of a transposable element is conceivably a more dynamic evolutionary 
transition than adaptation through point-mutations and deletions. We speculate that the insertion of IS1548 into 
the silB-gene confers a more aggressive and invasive bacterial phenotype through the downregulation of silCR. 
Furthermore, it is plausible that the process is reversible under certain environmental conditions, facilitating the 
return to a commensal state. The pathogenic mechanisms and bacterial signalling involved in this hypothesized 
transition have yet to be explored, and deserves further investigation.
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A genetic dissection of the stG62647-isolates revealed the presence of several important virulence factors, 
including genes involved in immune evasion (emm, protein G and c5a-peptidase), adhesion (dltABCD, fbp54, 
gapC, shr and lmb), tissue penetration (streptokinase) and toxins (streptolysin O and streptolysin S). However, these 
genes appear to be ubiquitous in SDSE, and are thus unlikely to have a pivotal role in the successful epidemic 
spread and observed disease severity of stG626475. The differentially distributed speG was identified in all the 
CC20-isolates. speG does not confer superantigen-activity, though, and a correlation with disease severity has not 
been demonstrated40, 41. The covRS-regulon was conserved among the stG62647-isolates, and all showed a single 
amino acid substitution in covS, I421V, as compared to GGS124. However, a valine residue in this position is also 
present in wild type S. pyogenes-isolates, thus unlikely to be of clinical significance42.
Although bacteriophages were encountered in a subset of the isolates, no established or putative phage-associated 
virulence genes were detected. The CRISPR-cas system constitutes a part of the adaptive immune system in prokaryotic 
cells, conferring resistance to mobile genetic elements and bacteriophages43. Previous encounters with bacteriophages 
are deposited in the CRIPSR-locus as short sequence-specific DNA-fragments termed spacers. For S. pyogenes, an 
inverse relationship between the number of spacers and susceptibility to bacteriophages has been reported43. We did not 
observe such an association among our SDSE-isolates, albeit the frequency of bacteriophages was very low. We found 
our SDSE-isolates to contain markedly fewer bacteriophages and a higher number of spacers than S. pyogenes-genomes 
currently deposited in GenBank. Similar observations were reported by Shimomura et al., and a CRISPR-mediated 
increased resistance to bacteriophage-infection among SDSE compared to S. pyogenes is conceivable44.
The present study has some limitations. First, the partial retrospective design increased the risk of diagnostic 
misclassification, potentially leading to the underestimation of invasive SDSE and stG62647-infections. However, 
a scrutinous review of medical records likely led to the inclusion of all relevant SDSE cases in our region during 
the study period. Secondly, we acknowledge that the rise and fall of epidemic lineages of microbes is multifactorial, 
and although bacterial genetic events undoubtedly are contributory, knowledge on the prevalence of the outbreak 
genotype in asymptomatic carriers, along with the protective specific immunity in our population during the study 
period, would have increased our understanding of this stG62647-outbreak. Lastly, several of our proposed patho-
genic mechanisms are based on extrapolation of experimental data from closely related species, as knowledge on vir-
ulence properties in SDSE is scarce. A substantial fraction of the genetic repertoire specific for the stG62647-lineage 
encodes hypothetical proteins, and their pathogenic contribution is difficult to ascertain within the confines of cur-
rent knowledge. Hence, the possibility that the observed virulence potential of the stG62647-isolates emanates from 
any of these genetic elements cannot be ruled out. Furthermore, the significance of an insertional element in the 
silB-gene has not been verified experimentally, and its contribution to disease invasiveness or microenvironmental 
adaptation has yet to be elucidated. Ideally, the sil-locus should be examined from stG62647-isolates collected from 
different ecological niches, including asymptomatic carriers. A final conclusion could be obtained after the dele-
tion of IS1548 from the silB gene of one of the stG62647-strain and the comparison of the virulence of the deletion 
mutant and the wild-type strain in an animal model. Adaptive virulence regulation through insertional elements 
constitutes an intriguing concept, and further studies are warranted.
Conclusions
We report the emergence of a novel and virulent SDSE genotype, stG62647, in our health region. The infections 
associated with stG62647 appeared to pursue a severe clinical course, including the occurrence of streptococcal toxic 
shock syndrome, necrotizing soft-tissue infections and endocarditis. We speculate that its virulence could be partly 
attributable to the insertion of a transposable element, IS1548, into the streptococcal invasive locus (sil), thus abro-
gating the virulence attenuating control exerted by this regulon. Invasive SDSE disease is currently three times more 
common than invasive S. pyogenes infections in our region, and sustained epidemiological attentiveness is indicated.
Ethical considerations. The study underwent institutional ethics review and approval (2010/1406 Regional 
Ethics Committee West, Norway). Informed consent was obtained from participants. All experiments were car-
ried out in full accordance with the approved ethics applications specified above.
Availability of data and materials. The genomes of the stG62647-isolates have been deposited in the SRA 
GenBank database under the study accession number SRP103012 (www.ncbi.nlm.nih.gov/sra). Isolate T642 has 
been deposited at DDBJ/ENA/GenBank under the accession NBUZ00000000, the version described in this paper 
is version NBUZ01000000. The streptococcal invasive locus containing a truncated silB-gene due to the insertion 
of IS1548, is deposited in GenBank under the accession number KY807567.
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